Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04313946Unknown

Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays

Role: lead

NCT04325867Not ApplicableUnknown

Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19

Role: lead

NCT03393065Not ApplicableUnknown

Lung Ultrasound Guided Protocol for Fluid Management for the Critically Ill Patient: a Randomized Study

Role: lead

All 3 trials loaded